Text on a gradient background from green to blue reads: "Even with improved tools, innovation alone is insufficient without systems that support adoption." In the top left corner, the ASCO logo is displayed.

As the burden of GU cancers in older adults increases, we need to incorporate geriatric oncology principles into routine cancer care. Read more from #ASCOEdBook: https://bit.ly/3ZYGKaC

Authored by: @tullikagarg.bsky.social et al.
#GU26

🎙️ @hoperugo.bsky.social of @cityofhope.bsky.social & @viveksubbiah.bsky.social of Sarah Cannon Research Institute discuss innovative trial designs, treatment strategies, and key insights on the future of rare cancer research on the ASCO Education #BytheBook Podcast. url-shortener.me/820P
#ASCOEdBook

Kamaria Lee and Fumiko Chino on Financial Toxicity and Breast Cancer Still needed: interventions at government, institutional, and provider levels

New in @medpagetoday.com: Financial side effects from #breastcancer treatment can create life-altering problems, including distress, debt, & employment disruptions #bcsm #financialToxicity

Proud of the work of @mdanderson.bsky.social PGY5 Dr Kamaria Lee in the @ascocancer.bsky.social
#ASCOEdBook

Dr. Hope Rugo of @cityofhope.bsky.social and Dr. Kamaria Lee of @mdanderson.bsky.social discuss novel approaches to mitigate financial toxicity for patients with breast cancer globally on the ASCO Education #BytheBook Podcast: brnw.ch/21wUQV6
#ASCOEdBook

Interventions to Reduce Financial Toxicity in Breast Cancer | Podcast | ASCO Publications Dr. Hope Rugo and Dr. Kamaria Lee discuss the prevalence of financial toxicity in cancer care in the United States and globally, focusing on breast cancer, and highlight key interventions to mitigate ...

New #BytheBook #ASCOEdBook @ascocancer.bsky.social Podcast with Drs Hope Rugo and @mdanderson.bsky.social #radonc resident Dr Kamaria Lee discussing #financialToxicity in #breastCancer #bcsm and how to fix it.

📚 ascopubs.org/doi/10.1200/...

🎙️ ascopubs.org/do/intervent...

New #ASCOEdBook article: Dr. Dwight Owen and @benjaminbessemd.bsky.social et al review advances that led to the current standard of care for surgical and peri-operative management in resectable NSCLC and highlight ongoing and future directions of study.

Learn more: brnw.ch/21wTvIt

The #ASCOEdBook 2025 collection is now complete.
Check out the full edition: bit.ly/44bvEkk

How can we better support #BreastCancer survivors during follow-up care? A new #ASCOEdBook review explores strategies for managing therapy side effects and the potential of eHealth to improve care delivery.

Learn more: bit.ly/4mVIOKF

This #ASCOEdBook paper discusses the advances in targeted therapies & immunotherapies to treat #PancreaticCancer & cautions that clinical trials should answer questions that matter to patients.

Learn more: brnw.ch/21wTgZn

State of the Art: Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer.

Learn more: brnw.ch/21wTdI3
#ASCOEdBook #ASCO25 #mCRCPC #pcsm

Missed ASCO25? #ASCOEdBook provides the latest updates in clinical care, authored by ASCO ed session faculty. Learn more: brnw.ch/21wTbv2

Community engagement represents a foundational strategy for advancing cancer research and improving health outcomes. This study examines advocacy as a form of community engagement across the cancer research continuum: ascopubs.org/doi/10.1200/...
#ASCOEdBook

Supplement your #ASCO25 experience with #ASCOEdBook review articles: brnw.ch/21wT3Uu

Tomorrow's #ASCO25 Education Session on "When and How Long to Treat Chronic #LymphocyticLeukemia" has an accompanying #ASCOEdBook paper. Take a look: ascopubs.org/doi/10.1200/...
#lymsm

An understanding of the pathogenesis of treatment-related complications can inform therapeutic strategies for childhood cancer survivors. Read more: brnw.ch/21wSR1B
#ASCOEdBook

Prepping for #ASCO25? Preview education sessions with the #ASCOEdBook. New articles publish daily, authored by meeting faculty.

Visit: brnw.ch/21wSONS

Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs

New Treatment Options for Non-Muscle-Invasive Bladder Cancer from #ASCOEdBook: ascopubs.org/doi/10.1200/... #GU25 #oncsky

How can we apply current evidence to employ ctDNA in the optimal management of bladder cancer? #ASCOEdBook #GU25 ascopubs.org/doi/10.1200/...

Your comprehensive review of antibody-drug conjugates in #urothelialcarcinoma w/ highlights on ongoing development strategies in drug engineering and clinical trials from #ASCOEdBook #GU25: ascopubs.org/doi/10.1200/...

Supplement your #GU25 experience with #ASCOEdBook review articles: ascopubs.org/toc/edbk/45/2

New from#GI25 #ASCOEdBook: Cell-based therapies in GI cancers are promising. However, maintaining activity in the immunosuppressive tumor microenvironment must be addressed. brnw.ch/21wQfqx

Excited to release the first issues of the 2025 #ASCOEdBook!

And excited to see @ascocancer.bsky.social making the move to 🦋!

Supplement your #GI25 experience with #ASCOEdBook review articles: brnw.ch/21wQeaY

Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers Data have matured to support incorporation of integrative oncology modalities into comprehensive cancer care. Clinical practice guidelines have recently been published by ASCO for diet and exercise (2...

Don't miss #ASCOEdBook #GI25 edition with Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers ascopubs.org/doi/10.1200/...

Cell-Based Therapies in GI Cancers: Current Landscape and Future Directions Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid tum...

NEW #ASCOEdBook #GI25 article just published: Cell-Based Therapies in GI Cancers: Current Landscape and Future Directions ascopubs.org/doi/10.1200/...